Median times from randomization to progression , death , prostate cancer death and treatment failure in M0 and M1 patients were 46.8 and 21.4 , 57.6 and 40.3 , 59.5 and 40.7 , and 41.9 and 20.0 months , respectively ( p < 0.001 ) .